Abstract:AIM: To clone flagellin genes A (flaA) and B (flaB) from a clinical strain of Helicobacter pylori(Hpylori) and to construct prokaryotic expression systems of the genes and identify immunity of the fusion proteins.METHODS: The flaA and flaB genes from a clinical Hpylori isolate Y06 were amplified by high fidelity PCR. The nucleotide sequences of target DNA amplification fragments from the two genes were sequenced after T-A cloning. The recombinant expression vector pET32a inserted with flaA and flaB genes was constructed, respectively. The expressions of FlaA and FlaB fusion proteins in E. coli BL21DE3 induced by isopropylthio-p-D-galactoside (IPTG) at different concentrations were examined by SIDS-PAGE. Western blot using commercial antibodies against whole cell of H pylori and immunodiffusion assay using self-prepared rabbit antiserum against FlaA (rFlaA) or FlaB (rFlaB) recombinant proteins were applied to the determination of the fusion proteins immunity. ELISA was used to detect the antibodies against rFlaA and rFlaB in sera of 125 Hpylori infected patients and to examine rFlaA and rFlaB expression in 98 clinical isolates of H pylori, respectively.RESULTS: In comparison with the reported corresponding sequences, the nucleotide sequence homologies of the cloned flaA and flaB genes were from 96.28-97.13% and 96.31-97.73%, and their putative amino acid sequence homologies were 99.61-99.80% and 99.41-100% for the two genes, respectively. The output of rFlaA and rFlaB expressed by pET32a-flaA-BL21DE3 and pET32J-flaB-BL21DE3 systems was as high as 40-50% of the total bacterial proteins. Both rFlaA and rFlaB were able to combine with the commercial antibodies against whole cell of Hpylori and to induce rabbits to produce specific antibodies with the same 1:2 immunodiffusion titers after the animals were immunized with the two recombinant proteins. Ninety-eight and zero point 4 and 92.80% of the serum samples from 125 patients infected with Hpylori were positive for rFlaA and rFlaB antibodies, respectively. One hundred percent and 98.98% of the 98 tested isolates of H pylori were detectable for rFlaA and rFlaB epitopes, respectively.CONCLUSION: Two prokaryotic expression systems with high efficiency of H pylori flaA and flaB genes were successfully established. The expressed rFlaA and rFlaB showed satisfactory immunoreactivity and antigenicity. High frequencies of FlaA and FlaB expression in different Hpylori clinical strains and the general existence of specific antibodies against FlaA and FlaB in Hpylori infected patients strongly indicate that FlaA and FlaB are excellent antigen candidates for developing H pylori vaccine.

Construction of Prokaryotic Expression System of Ltb-Ureb Fusion Gene and Identification of the Recombinant Protein Immunity and Adjuvanticity

Construction of prokaryotic expression system of ureB gene from a clinical isolate of Helicobacter pylori and identification of immunogenicity of the fusion protein

Construction of prokaryotic expression system of<i>ureB</i>gene from a clinical<i>Helicobacter pylori</i>strain and identification of the recombinant protein immunity

Construction of Prokaryotic Expression System of Ureb Gene from a Clinical Helicobacter Pylori Strain and Identification of the Recombinant Protein Immunity.

Identification and Immunoprotective Effect of Prokaryotic Expression Product of Ltb-Hpaa Fusion Gene

Reconstruction of the Heat-Labile Enterotoxin Subunit B Gene of Escherichia Coli and Its Immune Adjuvant Activity on Mucosa

Immunoprotection of Recombinant Antigen LTB-UreB-HpaA in Helicobacter Pylori Infected Mice and Immunoenhancement of the Inner Adjuvant LTB

Construction of Expression Systems for Flaa and Flab Genes of Helicobacter Pylori and Determination of Immunoreactivity and Antigenicity of Recombinant Proteins.

Expression of the C-terminal 26 kDa fragment of Helicobacter pylori UreB in Escherichia coli and its immunity

Determination of fbe mucosal immunoadjuvantivity of recombinant EschericMa cott LTKA63 mutant and LTB

[Immunoprotective Effects of Helicobacter Pylori UreB and HpaA Bivalence Recombinant Vaccine with Inner Adjuvant on Experimental Infection in Mice].

Construction of Hpaa Gene from A Clinical Isolate of Helicobacter Pylori and Identification of Fusion Protein

[Cloning, Expression and Identification of Hpaa Gene from a Clinical Isolate of Helicobacter Pylori].

Oral Vaccination of Mice Against Helicobacter Pylori with Recombinant Lactococcus Lactis Expressing Urease Subunit B.

Detecting of Urease Subunit B in Serum from Patients with Helicobacter Pylori Infection

Construction and expression of fusion expression vector of Escherichia coli LTB and Helicobacter pylori HSPA

Construction of a prokaryotic expression system of vacA gene and detection of vacA gene, VacA protein in Helicobacter pylori isolates and ant-VacA antibody in patients' sera.

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

Cloning and Expression of Fragment with 2148 Bp from Caga Gene from Isolates of a Helicobacter Pylori and Identification of Immunogenicity of the Recombinant Proteins

Construction of Prokaryotic Expression System of 2 148-Bp Fragment from Caga Gene and Detection of Caga Gene, Caga Protein in Helicobacter Pylori Isolates and Its Antibody in Sera of Patients

Identification on the Immunogenic Activity of Recombinant Rltb/ctb-Lipl41/ 1 to Leptospira Interrogans and Detection of Lipl41 Gene with Its Production